{name}
{subtitle}
A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy
city
~34 mi. (Rogers, Arkansas, +32 more cities)
facility
Highlands Oncology Group
biomarker
ER Negative, +4 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
hormone therapy, +1 more drug
drug type
hormone therapy, +1 more type
A Study of APG-115 in Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
city
~34 mi. (Rogers, Arkansas, +15 more cities)
facility
Highlands Oncology
condition
Malignant Solid Tumor, +1 more condition
drug
alrizomadlin, +1 more drug
drug type
immunotherapy, +1 more type
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.
city
~43 mi. (Springdale, Arkansas, +230 more cities)
facility
Research Site
biomarker
ER Positive, +1 more biomarker
drug
camizestrant, +3 more drugs
drug type
hormone therapy, +1 more type